Pharma & Healthcare
Global FPR1 Inhibitor Market Research Report 2025
- Sep 24, 25
- ID: 521491
- Pages: 86
- Figures: 79
- Views: 3
Report Scope
This report aims to provide a comprehensive presentation of the global market for FPR1 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FPR1 Inhibitor.
The FPR1 Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global FPR1 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the FPR1 Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Bio-Techne
Abcam
ApexBio Technology
TargetMol Chemicals
GLPBio
ProbeChem Biochemicals
MedChemExpress
Segment by Type
FPR1 Antagonists
Indirect Inhibitors
Antibody Blockers
Others
Segment by Application
Pharma/Biotech
Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of FPR1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of FPR1 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for FPR1 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FPR1 Inhibitor.
The FPR1 Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global FPR1 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the FPR1 Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Bio-Techne
Abcam
ApexBio Technology
TargetMol Chemicals
GLPBio
ProbeChem Biochemicals
MedChemExpress
Segment by Type
FPR1 Antagonists
Indirect Inhibitors
Antibody Blockers
Others
Segment by Application
Pharma/Biotech
Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of FPR1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of FPR1 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 FPR1 Inhibitor Market Overview
1.1 Product Definition
1.2 FPR1 Inhibitor by Type
1.2.1 Global FPR1 Inhibitor Market Value Comparison by Type (2024 VS 2031)
1.2.2 FPR1 Antagonists
1.2.3 Indirect Inhibitors
1.2.4 Antibody Blockers
1.2.5 Others
1.3 FPR1 Inhibitor by Application
1.3.1 Global FPR1 Inhibitor Market Value by Application (2024 VS 2031)
1.3.2 Pharma/Biotech
1.3.3 Research
1.3.4 Other
1.4 Global FPR1 Inhibitor Market Size Estimates and Forecasts
1.4.1 Global FPR1 Inhibitor Revenue 2020-2031
1.4.2 Global FPR1 Inhibitor Sales 2020-2031
1.4.3 Global FPR1 Inhibitor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 FPR1 Inhibitor Market Competition by Manufacturers
2.1 Global FPR1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
2.2 Global FPR1 Inhibitor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global FPR1 Inhibitor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application
2.7 Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry
2.8 Global FPR1 Inhibitor Market Competitive Situation and Trends
2.8.1 Global FPR1 Inhibitor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest FPR1 Inhibitor Players Market Share by Revenue
2.8.3 Global FPR1 Inhibitor Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global FPR1 Inhibitor Market Scenario by Region
3.1 Global FPR1 Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global FPR1 Inhibitor Sales by Region: 2020-2031
3.2.1 Global FPR1 Inhibitor Sales by Region: 2020-2025
3.2.2 Global FPR1 Inhibitor Sales by Region: 2026-2031
3.3 Global FPR1 Inhibitor Revenue by Region: 2020-2031
3.3.1 Global FPR1 Inhibitor Revenue by Region: 2020-2025
3.3.2 Global FPR1 Inhibitor Revenue by Region: 2026-2031
3.4 North America FPR1 Inhibitor Market Facts & Figures by Country
3.4.1 North America FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America FPR1 Inhibitor Sales by Country (2020-2031)
3.4.3 North America FPR1 Inhibitor Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe FPR1 Inhibitor Market Facts & Figures by Country
3.5.1 Europe FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe FPR1 Inhibitor Sales by Country (2020-2031)
3.5.3 Europe FPR1 Inhibitor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FPR1 Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific FPR1 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific FPR1 Inhibitor Sales by Region (2020-2031)
3.6.3 Asia Pacific FPR1 Inhibitor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America FPR1 Inhibitor Market Facts & Figures by Country
3.7.1 Latin America FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America FPR1 Inhibitor Sales by Country (2020-2031)
3.7.3 Latin America FPR1 Inhibitor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa FPR1 Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa FPR1 Inhibitor Sales by Country (2020-2031)
3.8.3 Middle East and Africa FPR1 Inhibitor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global FPR1 Inhibitor Sales by Type (2020-2031)
4.1.1 Global FPR1 Inhibitor Sales by Type (2020-2025)
4.1.2 Global FPR1 Inhibitor Sales by Type (2026-2031)
4.1.3 Global FPR1 Inhibitor Sales Market Share by Type (2020-2031)
4.2 Global FPR1 Inhibitor Revenue by Type (2020-2031)
4.2.1 Global FPR1 Inhibitor Revenue by Type (2020-2025)
4.2.2 Global FPR1 Inhibitor Revenue by Type (2026-2031)
4.2.3 Global FPR1 Inhibitor Revenue Market Share by Type (2020-2031)
4.3 Global FPR1 Inhibitor Price by Type (2020-2031)
5 Segment by Application
5.1 Global FPR1 Inhibitor Sales by Application (2020-2031)
5.1.1 Global FPR1 Inhibitor Sales by Application (2020-2025)
5.1.2 Global FPR1 Inhibitor Sales by Application (2026-2031)
5.1.3 Global FPR1 Inhibitor Sales Market Share by Application (2020-2031)
5.2 Global FPR1 Inhibitor Revenue by Application (2020-2031)
5.2.1 Global FPR1 Inhibitor Revenue by Application (2020-2025)
5.2.2 Global FPR1 Inhibitor Revenue by Application (2026-2031)
5.2.3 Global FPR1 Inhibitor Revenue Market Share by Application (2020-2031)
5.3 Global FPR1 Inhibitor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck FPR1 Inhibitor Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne FPR1 Inhibitor Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam FPR1 Inhibitor Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 ApexBio Technology
6.4.1 ApexBio Technology Company Information
6.4.2 ApexBio Technology Description and Business Overview
6.4.3 ApexBio Technology FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ApexBio Technology FPR1 Inhibitor Product Portfolio
6.4.5 ApexBio Technology Recent Developments/Updates
6.5 TargetMol Chemicals
6.5.1 TargetMol Chemicals Company Information
6.5.2 TargetMol Chemicals Description and Business Overview
6.5.3 TargetMol Chemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TargetMol Chemicals FPR1 Inhibitor Product Portfolio
6.5.5 TargetMol Chemicals Recent Developments/Updates
6.6 GLPBio
6.6.1 GLPBio Company Information
6.6.2 GLPBio Description and Business Overview
6.6.3 GLPBio FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GLPBio FPR1 Inhibitor Product Portfolio
6.6.5 GLPBio Recent Developments/Updates
6.7 ProbeChem Biochemicals
6.7.1 ProbeChem Biochemicals Company Information
6.7.2 ProbeChem Biochemicals Description and Business Overview
6.7.3 ProbeChem Biochemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ProbeChem Biochemicals FPR1 Inhibitor Product Portfolio
6.7.5 ProbeChem Biochemicals Recent Developments/Updates
6.8 MedChemExpress
6.8.1 MedChemExpress Company Information
6.8.2 MedChemExpress Description and Business Overview
6.8.3 MedChemExpress FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MedChemExpress FPR1 Inhibitor Product Portfolio
6.8.5 MedChemExpress Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FPR1 Inhibitor Industry Chain Analysis
7.2 FPR1 Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FPR1 Inhibitor Production Mode & Process Analysis
7.4 FPR1 Inhibitor Sales and Marketing
7.4.1 FPR1 Inhibitor Sales Channels
7.4.2 FPR1 Inhibitor Distributors
7.5 FPR1 Inhibitor Customer Analysis
8 FPR1 Inhibitor Market Dynamics
8.1 FPR1 Inhibitor Industry Trends
8.2 FPR1 Inhibitor Market Drivers
8.3 FPR1 Inhibitor Market Challenges
8.4 FPR1 Inhibitor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 FPR1 Inhibitor by Type
1.2.1 Global FPR1 Inhibitor Market Value Comparison by Type (2024 VS 2031)
1.2.2 FPR1 Antagonists
1.2.3 Indirect Inhibitors
1.2.4 Antibody Blockers
1.2.5 Others
1.3 FPR1 Inhibitor by Application
1.3.1 Global FPR1 Inhibitor Market Value by Application (2024 VS 2031)
1.3.2 Pharma/Biotech
1.3.3 Research
1.3.4 Other
1.4 Global FPR1 Inhibitor Market Size Estimates and Forecasts
1.4.1 Global FPR1 Inhibitor Revenue 2020-2031
1.4.2 Global FPR1 Inhibitor Sales 2020-2031
1.4.3 Global FPR1 Inhibitor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 FPR1 Inhibitor Market Competition by Manufacturers
2.1 Global FPR1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
2.2 Global FPR1 Inhibitor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global FPR1 Inhibitor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application
2.7 Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry
2.8 Global FPR1 Inhibitor Market Competitive Situation and Trends
2.8.1 Global FPR1 Inhibitor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest FPR1 Inhibitor Players Market Share by Revenue
2.8.3 Global FPR1 Inhibitor Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global FPR1 Inhibitor Market Scenario by Region
3.1 Global FPR1 Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global FPR1 Inhibitor Sales by Region: 2020-2031
3.2.1 Global FPR1 Inhibitor Sales by Region: 2020-2025
3.2.2 Global FPR1 Inhibitor Sales by Region: 2026-2031
3.3 Global FPR1 Inhibitor Revenue by Region: 2020-2031
3.3.1 Global FPR1 Inhibitor Revenue by Region: 2020-2025
3.3.2 Global FPR1 Inhibitor Revenue by Region: 2026-2031
3.4 North America FPR1 Inhibitor Market Facts & Figures by Country
3.4.1 North America FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America FPR1 Inhibitor Sales by Country (2020-2031)
3.4.3 North America FPR1 Inhibitor Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe FPR1 Inhibitor Market Facts & Figures by Country
3.5.1 Europe FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe FPR1 Inhibitor Sales by Country (2020-2031)
3.5.3 Europe FPR1 Inhibitor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FPR1 Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific FPR1 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific FPR1 Inhibitor Sales by Region (2020-2031)
3.6.3 Asia Pacific FPR1 Inhibitor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America FPR1 Inhibitor Market Facts & Figures by Country
3.7.1 Latin America FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America FPR1 Inhibitor Sales by Country (2020-2031)
3.7.3 Latin America FPR1 Inhibitor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa FPR1 Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa FPR1 Inhibitor Sales by Country (2020-2031)
3.8.3 Middle East and Africa FPR1 Inhibitor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global FPR1 Inhibitor Sales by Type (2020-2031)
4.1.1 Global FPR1 Inhibitor Sales by Type (2020-2025)
4.1.2 Global FPR1 Inhibitor Sales by Type (2026-2031)
4.1.3 Global FPR1 Inhibitor Sales Market Share by Type (2020-2031)
4.2 Global FPR1 Inhibitor Revenue by Type (2020-2031)
4.2.1 Global FPR1 Inhibitor Revenue by Type (2020-2025)
4.2.2 Global FPR1 Inhibitor Revenue by Type (2026-2031)
4.2.3 Global FPR1 Inhibitor Revenue Market Share by Type (2020-2031)
4.3 Global FPR1 Inhibitor Price by Type (2020-2031)
5 Segment by Application
5.1 Global FPR1 Inhibitor Sales by Application (2020-2031)
5.1.1 Global FPR1 Inhibitor Sales by Application (2020-2025)
5.1.2 Global FPR1 Inhibitor Sales by Application (2026-2031)
5.1.3 Global FPR1 Inhibitor Sales Market Share by Application (2020-2031)
5.2 Global FPR1 Inhibitor Revenue by Application (2020-2031)
5.2.1 Global FPR1 Inhibitor Revenue by Application (2020-2025)
5.2.2 Global FPR1 Inhibitor Revenue by Application (2026-2031)
5.2.3 Global FPR1 Inhibitor Revenue Market Share by Application (2020-2031)
5.3 Global FPR1 Inhibitor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck FPR1 Inhibitor Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne FPR1 Inhibitor Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam FPR1 Inhibitor Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 ApexBio Technology
6.4.1 ApexBio Technology Company Information
6.4.2 ApexBio Technology Description and Business Overview
6.4.3 ApexBio Technology FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ApexBio Technology FPR1 Inhibitor Product Portfolio
6.4.5 ApexBio Technology Recent Developments/Updates
6.5 TargetMol Chemicals
6.5.1 TargetMol Chemicals Company Information
6.5.2 TargetMol Chemicals Description and Business Overview
6.5.3 TargetMol Chemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TargetMol Chemicals FPR1 Inhibitor Product Portfolio
6.5.5 TargetMol Chemicals Recent Developments/Updates
6.6 GLPBio
6.6.1 GLPBio Company Information
6.6.2 GLPBio Description and Business Overview
6.6.3 GLPBio FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GLPBio FPR1 Inhibitor Product Portfolio
6.6.5 GLPBio Recent Developments/Updates
6.7 ProbeChem Biochemicals
6.7.1 ProbeChem Biochemicals Company Information
6.7.2 ProbeChem Biochemicals Description and Business Overview
6.7.3 ProbeChem Biochemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ProbeChem Biochemicals FPR1 Inhibitor Product Portfolio
6.7.5 ProbeChem Biochemicals Recent Developments/Updates
6.8 MedChemExpress
6.8.1 MedChemExpress Company Information
6.8.2 MedChemExpress Description and Business Overview
6.8.3 MedChemExpress FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MedChemExpress FPR1 Inhibitor Product Portfolio
6.8.5 MedChemExpress Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FPR1 Inhibitor Industry Chain Analysis
7.2 FPR1 Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FPR1 Inhibitor Production Mode & Process Analysis
7.4 FPR1 Inhibitor Sales and Marketing
7.4.1 FPR1 Inhibitor Sales Channels
7.4.2 FPR1 Inhibitor Distributors
7.5 FPR1 Inhibitor Customer Analysis
8 FPR1 Inhibitor Market Dynamics
8.1 FPR1 Inhibitor Industry Trends
8.2 FPR1 Inhibitor Market Drivers
8.3 FPR1 Inhibitor Market Challenges
8.4 FPR1 Inhibitor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global FPR1 Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global FPR1 Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global FPR1 Inhibitor Market Competitive Situation by Manufacturers in 2024
Table 4. Global FPR1 Inhibitor Sales (g) of Key Manufacturers (2020-2025)
Table 5. Global FPR1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
Table 6. Global FPR1 Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global FPR1 Inhibitor Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market FPR1 Inhibitor Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application
Table 12. Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FPR1 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FPR1 Inhibitor as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global FPR1 Inhibitor Sales by Region (2020-2025) & (g)
Table 18. Global FPR1 Inhibitor Sales Market Share by Region (2020-2025)
Table 19. Global FPR1 Inhibitor Sales by Region (2026-2031) & (g)
Table 20. Global FPR1 Inhibitor Sales Market Share by Region (2026-2031)
Table 21. Global FPR1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global FPR1 Inhibitor Revenue Market Share by Region (2020-2025)
Table 23. Global FPR1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global FPR1 Inhibitor Revenue Market Share by Region (2026-2031)
Table 25. North America FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 27. North America FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 28. North America FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 32. Europe FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 33. Europe FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific FPR1 Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific FPR1 Inhibitor Sales by Region (2020-2025) & (g)
Table 37. Asia Pacific FPR1 Inhibitor Sales by Region (2026-2031) & (g)
Table 38. Asia Pacific FPR1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific FPR1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 42. Latin America FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 43. Latin America FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 47. Middle East and Africa FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 48. Middle East and Africa FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global FPR1 Inhibitor Sales (g) by Type (2020-2025)
Table 51. Global FPR1 Inhibitor Sales (g) by Type (2026-2031)
Table 52. Global FPR1 Inhibitor Sales Market Share by Type (2020-2025)
Table 53. Global FPR1 Inhibitor Sales Market Share by Type (2026-2031)
Table 54. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2020-2025)
Table 55. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2026-2031)
Table 56. Global FPR1 Inhibitor Revenue Market Share by Type (2020-2025)
Table 57. Global FPR1 Inhibitor Revenue Market Share by Type (2026-2031)
Table 58. Global FPR1 Inhibitor Price (US$/mg) by Type (2020-2025)
Table 59. Global FPR1 Inhibitor Price (US$/mg) by Type (2026-2031)
Table 60. Global FPR1 Inhibitor Sales (g) by Application (2020-2025)
Table 61. Global FPR1 Inhibitor Sales (g) by Application (2026-2031)
Table 62. Global FPR1 Inhibitor Sales Market Share by Application (2020-2025)
Table 63. Global FPR1 Inhibitor Sales Market Share by Application (2026-2031)
Table 64. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2020-2025)
Table 65. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2026-2031)
Table 66. Global FPR1 Inhibitor Revenue Market Share by Application (2020-2025)
Table 67. Global FPR1 Inhibitor Revenue Market Share by Application (2026-2031)
Table 68. Global FPR1 Inhibitor Price (US$/mg) by Application (2020-2025)
Table 69. Global FPR1 Inhibitor Price (US$/mg) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Merck FPR1 Inhibitor Product
Table 74. Merck Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. Bio-Techne FPR1 Inhibitor Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. Abcam FPR1 Inhibitor Product
Table 84. Abcam Recent Developments/Updates
Table 85. ApexBio Technology Company Information
Table 86. ApexBio Technology Description and Business Overview
Table 87. ApexBio Technology FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. ApexBio Technology FPR1 Inhibitor Product
Table 89. ApexBio Technology Recent Developments/Updates
Table 90. TargetMol Chemicals Company Information
Table 91. TargetMol Chemicals Description and Business Overview
Table 92. TargetMol Chemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. TargetMol Chemicals FPR1 Inhibitor Product
Table 94. TargetMol Chemicals Recent Developments/Updates
Table 95. GLPBio Company Information
Table 96. GLPBio Description and Business Overview
Table 97. GLPBio FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. GLPBio FPR1 Inhibitor Product
Table 99. GLPBio Recent Developments/Updates
Table 100. ProbeChem Biochemicals Company Information
Table 101. ProbeChem Biochemicals Description and Business Overview
Table 102. ProbeChem Biochemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. ProbeChem Biochemicals FPR1 Inhibitor Product
Table 104. ProbeChem Biochemicals Recent Developments/Updates
Table 105. MedChemExpress Company Information
Table 106. MedChemExpress Description and Business Overview
Table 107. MedChemExpress FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 108. MedChemExpress FPR1 Inhibitor Product
Table 109. MedChemExpress Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. FPR1 Inhibitor Distributors List
Table 113. FPR1 Inhibitor Customers List
Table 114. FPR1 Inhibitor Market Trends
Table 115. FPR1 Inhibitor Market Drivers
Table 116. FPR1 Inhibitor Market Challenges
Table 117. FPR1 Inhibitor Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of FPR1 Inhibitor
Figure 2. Global FPR1 Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global FPR1 Inhibitor Market Share by Type: 2024 & 2031
Figure 4. FPR1 Antagonists Product Picture
Figure 5. Indirect Inhibitors Product Picture
Figure 6. Antibody Blockers Product Picture
Figure 7. Others Product Picture
Figure 8. Global FPR1 Inhibitor Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global FPR1 Inhibitor Market Share by Application: 2024 & 2031
Figure 10. Pharma/Biotech
Figure 11. Research
Figure 12. Other
Figure 13. Global FPR1 Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global FPR1 Inhibitor Market Size (2020-2031) & (US$ Million)
Figure 15. Global FPR1 Inhibitor Sales (2020-2031) & (g)
Figure 16. Global FPR1 Inhibitor Average Price (US$/mg) & (2020-2031)
Figure 17. FPR1 Inhibitor Report Years Considered
Figure 18. FPR1 Inhibitor Sales Share by Manufacturers in 2024
Figure 19. Global FPR1 Inhibitor Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest FPR1 Inhibitor Players: Market Share by Revenue in FPR1 Inhibitor in 2024
Figure 21. FPR1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 24. North America FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 25. United States FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 28. Europe FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 29. Germany FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific FPR1 Inhibitor Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific FPR1 Inhibitor Revenue Market Share by Region (2020-2031)
Figure 36. China FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 44. Latin America FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 45. Mexico FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 51. Turkey FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of FPR1 Inhibitor by Type (2020-2031)
Figure 55. Global Revenue Market Share of FPR1 Inhibitor by Type (2020-2031)
Figure 56. Global FPR1 Inhibitor Price (US$/mg) by Type (2020-2031)
Figure 57. Global Sales Market Share of FPR1 Inhibitor by Application (2020-2031)
Figure 58. Global Revenue Market Share of FPR1 Inhibitor by Application (2020-2031)
Figure 59. Global FPR1 Inhibitor Price (US$/mg) by Application (2020-2031)
Figure 60. FPR1 Inhibitor Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global FPR1 Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global FPR1 Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global FPR1 Inhibitor Market Competitive Situation by Manufacturers in 2024
Table 4. Global FPR1 Inhibitor Sales (g) of Key Manufacturers (2020-2025)
Table 5. Global FPR1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
Table 6. Global FPR1 Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global FPR1 Inhibitor Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market FPR1 Inhibitor Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application
Table 12. Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FPR1 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FPR1 Inhibitor as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global FPR1 Inhibitor Sales by Region (2020-2025) & (g)
Table 18. Global FPR1 Inhibitor Sales Market Share by Region (2020-2025)
Table 19. Global FPR1 Inhibitor Sales by Region (2026-2031) & (g)
Table 20. Global FPR1 Inhibitor Sales Market Share by Region (2026-2031)
Table 21. Global FPR1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global FPR1 Inhibitor Revenue Market Share by Region (2020-2025)
Table 23. Global FPR1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global FPR1 Inhibitor Revenue Market Share by Region (2026-2031)
Table 25. North America FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 27. North America FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 28. North America FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 32. Europe FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 33. Europe FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific FPR1 Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific FPR1 Inhibitor Sales by Region (2020-2025) & (g)
Table 37. Asia Pacific FPR1 Inhibitor Sales by Region (2026-2031) & (g)
Table 38. Asia Pacific FPR1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific FPR1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 42. Latin America FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 43. Latin America FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa FPR1 Inhibitor Sales by Country (2020-2025) & (g)
Table 47. Middle East and Africa FPR1 Inhibitor Sales by Country (2026-2031) & (g)
Table 48. Middle East and Africa FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global FPR1 Inhibitor Sales (g) by Type (2020-2025)
Table 51. Global FPR1 Inhibitor Sales (g) by Type (2026-2031)
Table 52. Global FPR1 Inhibitor Sales Market Share by Type (2020-2025)
Table 53. Global FPR1 Inhibitor Sales Market Share by Type (2026-2031)
Table 54. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2020-2025)
Table 55. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2026-2031)
Table 56. Global FPR1 Inhibitor Revenue Market Share by Type (2020-2025)
Table 57. Global FPR1 Inhibitor Revenue Market Share by Type (2026-2031)
Table 58. Global FPR1 Inhibitor Price (US$/mg) by Type (2020-2025)
Table 59. Global FPR1 Inhibitor Price (US$/mg) by Type (2026-2031)
Table 60. Global FPR1 Inhibitor Sales (g) by Application (2020-2025)
Table 61. Global FPR1 Inhibitor Sales (g) by Application (2026-2031)
Table 62. Global FPR1 Inhibitor Sales Market Share by Application (2020-2025)
Table 63. Global FPR1 Inhibitor Sales Market Share by Application (2026-2031)
Table 64. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2020-2025)
Table 65. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2026-2031)
Table 66. Global FPR1 Inhibitor Revenue Market Share by Application (2020-2025)
Table 67. Global FPR1 Inhibitor Revenue Market Share by Application (2026-2031)
Table 68. Global FPR1 Inhibitor Price (US$/mg) by Application (2020-2025)
Table 69. Global FPR1 Inhibitor Price (US$/mg) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Merck FPR1 Inhibitor Product
Table 74. Merck Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. Bio-Techne FPR1 Inhibitor Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. Abcam FPR1 Inhibitor Product
Table 84. Abcam Recent Developments/Updates
Table 85. ApexBio Technology Company Information
Table 86. ApexBio Technology Description and Business Overview
Table 87. ApexBio Technology FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. ApexBio Technology FPR1 Inhibitor Product
Table 89. ApexBio Technology Recent Developments/Updates
Table 90. TargetMol Chemicals Company Information
Table 91. TargetMol Chemicals Description and Business Overview
Table 92. TargetMol Chemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. TargetMol Chemicals FPR1 Inhibitor Product
Table 94. TargetMol Chemicals Recent Developments/Updates
Table 95. GLPBio Company Information
Table 96. GLPBio Description and Business Overview
Table 97. GLPBio FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. GLPBio FPR1 Inhibitor Product
Table 99. GLPBio Recent Developments/Updates
Table 100. ProbeChem Biochemicals Company Information
Table 101. ProbeChem Biochemicals Description and Business Overview
Table 102. ProbeChem Biochemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. ProbeChem Biochemicals FPR1 Inhibitor Product
Table 104. ProbeChem Biochemicals Recent Developments/Updates
Table 105. MedChemExpress Company Information
Table 106. MedChemExpress Description and Business Overview
Table 107. MedChemExpress FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 108. MedChemExpress FPR1 Inhibitor Product
Table 109. MedChemExpress Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. FPR1 Inhibitor Distributors List
Table 113. FPR1 Inhibitor Customers List
Table 114. FPR1 Inhibitor Market Trends
Table 115. FPR1 Inhibitor Market Drivers
Table 116. FPR1 Inhibitor Market Challenges
Table 117. FPR1 Inhibitor Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of FPR1 Inhibitor
Figure 2. Global FPR1 Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global FPR1 Inhibitor Market Share by Type: 2024 & 2031
Figure 4. FPR1 Antagonists Product Picture
Figure 5. Indirect Inhibitors Product Picture
Figure 6. Antibody Blockers Product Picture
Figure 7. Others Product Picture
Figure 8. Global FPR1 Inhibitor Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global FPR1 Inhibitor Market Share by Application: 2024 & 2031
Figure 10. Pharma/Biotech
Figure 11. Research
Figure 12. Other
Figure 13. Global FPR1 Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global FPR1 Inhibitor Market Size (2020-2031) & (US$ Million)
Figure 15. Global FPR1 Inhibitor Sales (2020-2031) & (g)
Figure 16. Global FPR1 Inhibitor Average Price (US$/mg) & (2020-2031)
Figure 17. FPR1 Inhibitor Report Years Considered
Figure 18. FPR1 Inhibitor Sales Share by Manufacturers in 2024
Figure 19. Global FPR1 Inhibitor Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest FPR1 Inhibitor Players: Market Share by Revenue in FPR1 Inhibitor in 2024
Figure 21. FPR1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 24. North America FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 25. United States FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 28. Europe FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 29. Germany FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific FPR1 Inhibitor Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific FPR1 Inhibitor Revenue Market Share by Region (2020-2031)
Figure 36. China FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 44. Latin America FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 45. Mexico FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa FPR1 Inhibitor Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
Figure 51. Turkey FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of FPR1 Inhibitor by Type (2020-2031)
Figure 55. Global Revenue Market Share of FPR1 Inhibitor by Type (2020-2031)
Figure 56. Global FPR1 Inhibitor Price (US$/mg) by Type (2020-2031)
Figure 57. Global Sales Market Share of FPR1 Inhibitor by Application (2020-2031)
Figure 58. Global Revenue Market Share of FPR1 Inhibitor by Application (2020-2031)
Figure 59. Global FPR1 Inhibitor Price (US$/mg) by Application (2020-2031)
Figure 60. FPR1 Inhibitor Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232